What can we learn about functional importance of human antimicrobial peptide LL-37 in the oral environment from severe congenital neutropenia (Kostmann disease)?
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Alfred Österlunds Stiftelse
This publication has 45 references indexed in Scilit:
- Salivary concentration of free LL-37 in edentulism, chronic periodontitis and healthy periodontiumArchives of Oral Biology, 2013
- LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblastsExperimental Dermatology, 2011
- Streptococcus mutansstrains recovered from caries‐active or caries‐free individuals differ in sensitivity to host antimicrobial peptidesMolecular Oral Microbiology, 2011
- The Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway EpitheliumAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Clinical implications of ELA2‐, HAX1‐, and G‐CSF‐receptor (CSF3R) mutations in severe congenital neutropeniaBritish Journal of Haematology, 2009
- The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent MannerJournal of Biological Chemistry, 2008
- Salivary Antimicrobial Peptide Expression and Dental Caries Experience in ChildrenAntimicrobial Agents and Chemotherapy, 2005
- Periodontal Status in Two Siblings With Severe Congenital Neutropenia: Diagnosis and Mutational Analysis of the CasesJournal of Periodontology, 2005
- Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37Journal of Biological Chemistry, 1998
- Infantile Genetic Agranulocytosis (Agranulocytosis infantilis hereditaria) A New Recessive Lethal Disease in ManActa Paediatrica, 1956